Siga Says Survey Will Bolster Bid For $2.8B Contract

Law360, New York (November 18, 2010, 3:06 PM EST) -- Siga Technologies Inc. said Thursday that a new market survey launched by the U.S. Department of Health and Human Services is likely to back the company's claims that the government's smallpox antiviral acquisition should not proceed as a small business set-aside contract.

Siga said that a survey launched by the HHS' Biomedical Advanced Research and Development Authority to determine whether there is sufficient capacity among qualified small businesses to supply a smallpox antiviral will only bolster the company's arguments in its fight against a recent decision...
To view the full article, register now.